cbdMD, Inc.
YCBD
Positions held
Your positionsYCBD isn't in your positions.
Add it to see shares, cost, and P&L here.
Fundamentals
| Market cap | $4.42M | Enterprise value | $4.52M | Trailing P/E | 1.72 | Forward P/E | -0.44 |
| PEG | — | Price / book | 0.53 | Beta | 2.25 | Dividend yield | 0.00% |
| Revenue growth | 20.6% | Earnings growth | — | Gross margin | 57.7% | Operating margin | -20.4% |
| Profit margin | -13.8% | ROE | -40.3% | ROA | -15.8% | Debt / equity | 0.27 |
| Current ratio | 2.50 | Free cash flow | -$1.05M | Analyst recommendation | none | Mean target | — |
| 52w high | $2.56 | 52w low | $0.38 |
Quarterly
| 2026-Q2 | 2026-Q1 | 2025-Q4 | 2025-Q3 | 2025-Q2 | 2025-Q1 | |
|---|---|---|---|---|---|---|
| Revenue | $5.6M | $5.6M | $5.0M | $4.7M | $4.6M | — |
| Op margin | -20.4% | -14.2% | -5.7% | -14.5% | -19.6% | — |
| Net income | -$1.1M | -$0.8M | -$0.3M | -$0.7M | -$0.9M | — |
| Gross margin | 54.7% | 57.7% | 59.8% | 58.8% | 61.5% | — |
| Gross profit | $3.0M | $3.3M | $3.0M | $2.8M | $2.8M | — |
| Operating income | -$1.1M | -$0.8M | -$0.3M | -$0.7M | -$0.9M | — |
- Revenue -2% vs prior quarter ($5.6M vs $5.6M).
- Gross margin 54.7% (was 57.7% prior quarter).
- Operating margin compressed to -20.4%.
Yearly (6y)
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Revenue | $19.2M | $19.5M | $24.2M | $35.4M |
| Op margin | -11.3% | -17.0% | -38.4% | -48.9% |
| Net income | -$2.0M | -$3.7M | -$22.9M | -$70.1M |
| Gross margin | 62.4% | 61.6% | 62.0% | 63.1% |
| Gross profit | $12.0M | $12.0M | $15.0M | $22.3M |
| Operating income | -$2.2M | -$3.3M | -$9.3M | -$17.3M |
No flags
• No distress or material-risk keywords in recent headlines (keyword scan only — not a guarantee).
News
2026-09-24 · Reserveage Launches Longev+ Exclusively at The Vitamin Shoppe, Bringing Strength Into the Healthy Aging Conversation
2026-08-14 · cbdMD Inc (YCBD) (Q3 2026) Earnings Call Highlights: Strategic Pivot and Cost Cuts Aim to ...
2026-08-13 · cbdMD Reports 20% Year-over-Year Revenue Growth for the Third Fiscal Quarter of 2026
2026-08-10 · cbdMD, Inc. to Host Conference Call to Discuss June 30, 2026, Third Quarter Results
2026-07-24 · cbdMD Supports the Bipartisan Lawful Hemp Protection Act to Protect Consumers and Full-Spectrum CBD Access
2026-07-14 · cbdMD's Oasis Brand Partners with Mexcor to Launch Into South Carolina
Price (daily)
Full chart · RSI · MACD · patterns